Qin Tingting, Qian Huimin, Fan Wenting, Ma Ping, Zhou Lu, Dong Chen, Gu Bing, Huo Xiang
Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002 China.
Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, 210009 China.
Antimicrob Resist Infect Control. 2017 Sep 19;6:97. doi: 10.1186/s13756-017-0249-1. eCollection 2017.
To determine the prevalence, antimicrobial susceptibility patterns and related presence of mutations in quinolone resistance-determining region (QRDR) genes and plasmid-mediated quinolone resistance (PMQR) among isolates obtained from Jiangsu Province, China.
A total of 400 clinical isolates collected during 2012-2015 were identified by biochemical and serological methods, and the antimicrobial susceptibility pattern was evaluated using the disc-diffusion method. PCR and DNA sequencing were accomplished to identify mutations in , , and , and the presence of , , , , , and genes were also detected.
Of all the , 75.8% were resistant to nalidixic acid, and 37.0% were categorized as norfloxacin resistant. Overall, 75.5% of isolates possessed mutations (Ser83Leu, Asp87Gly/Asn and His211Tyr), while 84.3% had mutations (Ser80Ile, Ala81Pho, Gln91His and Ser129Pro). The most prevalent point mutations in and were Ser83Leu (75.5%, 302/400) and Ser80Ile (74.5%, 298/400), relatively. Besides, the Gln517Arg alternation in was detected in 13 isolates and no mutations were identified in . PMQR determinations of , and were detected among 16 strains (4.0%).
The results presented here show that fluoroquinolone resistance in these clinical isolates result from mutations in chromosome, besides, despite the low prevalence of PMQR determinants in Jiangsu, it is essential to continue surveillance PMQR determinants in this area.
确定从中国江苏省分离出的菌株中喹诺酮耐药决定区(QRDR)基因和质粒介导的喹诺酮耐药性(PMQR)的流行情况、抗菌药物敏感性模式及相关突变情况。
采用生化和血清学方法对2012 - 2015年期间收集的400株临床分离株进行鉴定,并用纸片扩散法评估抗菌药物敏感性模式。进行PCR和DNA测序以鉴定gyrA、gyrB、parC和parE中的突变,同时检测qnrA、qnrB、qnrC、qnrD、qnrS、aac(6’)-Ib-cr和qepA基因的存在情况。
在所有分离株中,75.8%对萘啶酸耐药,37.0%被归类为对诺氟沙星耐药。总体而言,75.5%的分离株存在gyrA突变(Ser83Leu、Asp87Gly/Asn和His211Tyr),而84.3%有parC突变(Ser80Ile、Ala81Pho、Gln91His和Ser129Pro)。gyrA和parC中最常见的点突变分别为Ser83Leu(75.5%,302/400)和Ser80Ile(74.5%,298/400)。此外,在13株分离株中检测到parE中的Gln517Arg改变,而gyrB中未鉴定到突变。在16株菌株(4.0%)中检测到qnrA、qnrB和qnrS的PMQR测定结果。
此处呈现的结果表明,这些临床分离株中的氟喹诺酮耐药性源于染色体突变,此外,尽管江苏省PMQR决定因素的流行率较低,但继续监测该地区的PMQR决定因素至关重要。